Trial Profile
Comparison of the Effects of Ticagrelor Versus Clopidogrel on Endothelial Dysfunction and Vascular Inflammation in Patients With Prior Non-ST-segment Acute Coronary Syndrome
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 18 May 2016 Planned End Date changed from 1 Mar 2016 to 1 Mar 2017.
- 18 May 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016.
- 12 Mar 2015 New trial record